Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariangela Tosca

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Immunotherapy|December 18, 2013
Serum-specific IgE and allergen immunotherapy in allergic childrenMariangela Tosca, Michela Silvestri, Michela Sivestri, et al.
International Immunopharmacology|June 6, 2009
Two year sublingual immunotherapy affects serum leptinGiorgio Ciprandi, Mara De Amici, Mariangela Tosca, et al.
American Journal of Rhinology|December 22, 2006
Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitisGiorgio Ciprandi, Ignazio Cirillo, Catherine Klersy, et al.
Frontiers in Pediatrics|September 25, 2018
Anaphylactic Shock During Pediatric Anesthesia: An Unexpected Reaction to SevofluraneAlessandro Simonini, Etrusca Brogi, Brunella Gily, et al.
Expert Review of Respiratory Medicine|January 11, 2023
Respiratory comorbidities in severe asthma: focus on the pediatric ageAmelia Licari, Beatrice Andrenacci, Maria Elisa Di Cicco, et al.
Allergy and Asthma Proceedings|February 29, 2012
A forced expiratory flow at 25-75% value <65% of predicted should be considered abnormal: a real-world, cross-sectional studyGiorgio Ciprandi, Michele Capasso, Mariangela Tosca, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patientsIgnazio Cirillo, Catherine Klersy, Gian Luigi Marseglia, et al.
Acta Bio-Medica : Atenei Parmensis|November 29, 2021
Component resolved diagnosis and risk assessment in food allergyAlberto Martelli, Mauro Calvani, Thomas Foiadelli, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot studyGian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 2, 2024
From evidence to practice: A systematic review-based diagnostic algorithm for paediatric eosinophilia across socioeconomic contextRoberta Pellegrino, Mariangela Tosca, Edoardo Timitilli, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Immunotherapy|December 18, 2013
Serum-specific IgE and allergen immunotherapy in allergic childrenMariangela Tosca, Michela Silvestri, Michela Sivestri, et al.
International Immunopharmacology|June 6, 2009
Two year sublingual immunotherapy affects serum leptinGiorgio Ciprandi, Mara De Amici, Mariangela Tosca, et al.
American Journal of Rhinology|December 22, 2006
Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitisGiorgio Ciprandi, Ignazio Cirillo, Catherine Klersy, et al.
Frontiers in Pediatrics|September 25, 2018
Anaphylactic Shock During Pediatric Anesthesia: An Unexpected Reaction to SevofluraneAlessandro Simonini, Etrusca Brogi, Brunella Gily, et al.
Expert Review of Respiratory Medicine|January 11, 2023
Respiratory comorbidities in severe asthma: focus on the pediatric ageAmelia Licari, Beatrice Andrenacci, Maria Elisa Di Cicco, et al.
Allergy and Asthma Proceedings|February 29, 2012
A forced expiratory flow at 25-75% value <65% of predicted should be considered abnormal: a real-world, cross-sectional studyGiorgio Ciprandi, Michele Capasso, Mariangela Tosca, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patientsIgnazio Cirillo, Catherine Klersy, Gian Luigi Marseglia, et al.
Acta Bio-Medica : Atenei Parmensis|November 29, 2021
Component resolved diagnosis and risk assessment in food allergyAlberto Martelli, Mauro Calvani, Thomas Foiadelli, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot studyGian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 2, 2024
From evidence to practice: A systematic review-based diagnostic algorithm for paediatric eosinophilia across socioeconomic contextRoberta Pellegrino, Mariangela Tosca, Edoardo Timitilli, et al.
Pageof 4